Edition:
United States

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

11.11USD
12 Dec 2017
Change (% chg)

$-0.27 (-2.37%)
Prev Close
$11.38
Open
$11.46
Day's High
$11.46
Day's Low
$10.98
Volume
5,524
Avg. Vol
10,395
52-wk High
$14.52
52-wk Low
$7.30

Chart for

About

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a... (more)

Overall

Beta: --
Market Cap(Mil.): $155.34
Shares Outstanding(Mil.): 13.88
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 188.50 15.25
EPS (TTM): -- -- --
ROI: -- -11.67 33.27
ROE: -- -36.21 16.35

Earnings vs. Estimates